» Articles » PMID: 8286076

Syringe-mediated Drug-sharing (backloading): a New Risk Factor for HIV Among Injecting Drug Users

Overview
Journal AIDS
Date 1993 Dec 1
PMID 8286076
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In syringe-mediated drug-sharing (backloading), injecting drug users (IDU) use their syringes to mix drugs and to give measured shares to other IDU by squirting drug solution into the syringes of other IDU. Backloading has been discussed as a potential HIV risk factor, but its role as an HIV transmission route has not been established empirically.

Methods: Six hundred and sixty IDU who had injected drugs in the previous 2 years were street-recruited from Bushwick, New York City through chain referral, tested for HIV antibody and interviewed about sexual and drug-risk behaviors.

Results: Receiving drugs via backloading in the previous 2 years was reported by 24.5% of the subjects. These subjects had significantly higher HIV seroprevalence than those who did not receive drugs by backloading (odds ratio, 2.2; 95% confidence interval, 1.5-3.1). Backloading remained positively and significantly associated with HIV seropositivity in stepwise logistic regression, and in a series of simultaneous logistic models controlling for sociodemographic variables and for sexual and drug risk variables.

Conclusions: Backloading can be a route of HIV transmission among IDU and should be incorporated into risk-factor studies and HIV transmission modeling. Many IDU who avoid other high-risk drug-injection practices may overlook the risk of backloading. HIV prevention programs should warn IDU against syringe-mediated drug-sharing and work together to develop ways to avoid it.

Citing Articles

The correlates and predictive validity of HIV risk groups among drug users in a community-based sample: methodological findings from a multi-site cluster analysis.

Dennis M, Wechsberg W, McDermeit M, Campbell R, Rasch R Eval Program Plann. 2021; 24(2):187-206.

PMID: 34728868 PMC: 8559767. DOI: 10.1016/s0149-7189(01)00014-3.


Prescription drug use and misuse in a cohort of people who inject drugs (PWID) in Baltimore.

Anagnostopoulos A, Abraham A, Genberg B, Kirk G, Mehta S Addict Behav. 2018; 81:39-45.

PMID: 29425791 PMC: 5845821. DOI: 10.1016/j.addbeh.2018.01.024.


Recovery of Infectious Hepatitis C Virus From Injection Paraphernalia: Implications for Prevention Programs Serving People Who Inject Drugs.

Heimer R, Binka M, Koester S, Grund J, Patel A, Paintsil E J Infect Dis. 2017; 217(3):466-473.

PMID: 28968665 PMC: 5854006. DOI: 10.1093/infdis/jix427.


Trends in HIV and HCV Risk Behaviors and Prevalent Infection Among People Who Inject Drugs in New York City, 2005-2012.

Neaigus A, Reilly K, Jenness S, Hagan H, Wendel T, Gelpi-Acosta C J Acquir Immune Defic Syndr. 2017; 75 Suppl 3:S325-S332.

PMID: 28604434 PMC: 8284853. DOI: 10.1097/QAI.0000000000001407.


Integrated biological-behavioural surveillance in pandemic-threat warning systems.

Miller M, Hagan E Bull World Health Organ. 2017; 95(1):62-68.

PMID: 28053365 PMC: 5180348. DOI: 10.2471/BLT.16.175984.